1 Schmidtko J, "Treatment of atypical hemolytic uremic syndrome and thrombotic microangiopathies : a focus on eculizumab" 61 : 289-299, 2013
2 Scheiring J, "Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome(HUS)" 23 : 1749-1760, 2008
3 Ruggenenti P, "Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura" 60 : 831-846, 2001
4 Noris M, "Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype" 5 : 1844-1859, 2010
5 Huber-Lang M, "R. Complement therapeutic strategies in trauma, hemorrhagic shock and systemic inflammation - closing Pandora’s box?" 28 : 278-284, 2016
6 Weitz M, "Prophylactic eculizumab prior to kidney transplantation for atypical hemolytic uremic syndrome" 26 : 1325-1329, 2011
7 Nester C, "Pre-emptive eculizumab and plasmapheresis for renal transplant in atypical hemolytic uremic syndrome" 6 : 1488-1494, 2011
8 Constantinescu AR, "Non-enteropathic hemolytic uremic syndrome : causes and short-term course" 43 : 976-982, 2004
9 Jokiranta TS, "HUS and atypical HUS" 129 : 2847-2856, 2017
10 Caprioli J, "Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome" 108 : 1267-1279, 2006
1 Schmidtko J, "Treatment of atypical hemolytic uremic syndrome and thrombotic microangiopathies : a focus on eculizumab" 61 : 289-299, 2013
2 Scheiring J, "Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome(HUS)" 23 : 1749-1760, 2008
3 Ruggenenti P, "Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura" 60 : 831-846, 2001
4 Noris M, "Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype" 5 : 1844-1859, 2010
5 Huber-Lang M, "R. Complement therapeutic strategies in trauma, hemorrhagic shock and systemic inflammation - closing Pandora’s box?" 28 : 278-284, 2016
6 Weitz M, "Prophylactic eculizumab prior to kidney transplantation for atypical hemolytic uremic syndrome" 26 : 1325-1329, 2011
7 Nester C, "Pre-emptive eculizumab and plasmapheresis for renal transplant in atypical hemolytic uremic syndrome" 6 : 1488-1494, 2011
8 Constantinescu AR, "Non-enteropathic hemolytic uremic syndrome : causes and short-term course" 43 : 976-982, 2004
9 Jokiranta TS, "HUS and atypical HUS" 129 : 2847-2856, 2017
10 Caprioli J, "Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome" 108 : 1267-1279, 2006
11 Fremeaux-Bacchi V, "Genetics and outcome of atypical hemolytic uremic syndrome : a nationwide French series comparing children and adults" 8 : 554-562, 2013
12 Raina R, "Atypical hemolytic-uremic syndrome: an update on pathophysiology, diagnosis, and treatment" 23 : 4-21, 2019
13 Noris M, "Atypical hemolytic-uremic syndrome" 361 : 1676-1687, 2009
14 Laurence J, "Atypical hemolytic uremic syndrome(aHUS) : making the diagnosis" 10 (10): 1-12, 2012
15 Laurence J, "Atypical hemolytic uremic syndrome(aHUS) : essential aspects of an accurate diagnosis" 2016
16 Krishnappa V, "Atypical hemolytic uremic syndrome : a meta-analysis of case reports confirms the prevalence of genetic mutations and the shift of treatment regimens" 22 : 178-188, 2018
17 Loirat C, "An international consensus approach to the management of atypical hemolytic uremic syndrome in children" 31 : 15-39, 2016
18 Besbas N, "A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders" 70 : 423-431, 2006